NCT06399419
- Conditions
- Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma, +22 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Clinical trial condition
Advanced Renal Cell Carcinoma
Explore clinical trials studying Advanced Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.
51 public trials
12 recruiting studies
Advanced Renal Cell Carcinoma trial results
NCT05868174
- Conditions
- Advanced Renal Cell Carcinoma, Advanced Solid Tumor, Solid Tumor, Adult
- Locations
-
- Macquarie University North Ryde, New South Wales, Australia
- Ashford (Icon) Cancer Centre Adelaide, Australia
- Princess Alexandra Hospital Brisbane, Australia
- Austin Health Melbourne, Australia
Not yet recruiting
Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer
NCT07716735
- Conditions
- Adenocarcinoma, Advanced Kidney Carcinoma, Advanced Renal Cell Carcinoma, +28 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Not yet recruiting
Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma
NCT07500831
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
- Locations
-
- Qilu Hospital of Shandong University Jinan, Shandong, China
Not yet recruiting
RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy
NCT07218692
- Conditions
- Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma, +23 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
Not yet recruiting
Clinical Study of a Novel Humanized CD70-Targeted CAR-T Cell Incorporating TLR2 for Advanced Renal Cell Carcinoma Therapy
NCT07113977
- Conditions
- Advanced Renal Cell Carcinoma
- Locations
-
Not specified
Active, not recruiting
Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.
NCT03647878
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
- Locations
-
- Landeskrankenhaus Hochsteiermark Leoben, Austria
- Kepler Universitätsklinikum GmbH Linz, Austria
- Uniklinikum Salzburg Salzburg, Austria
- Salzkammergutklinikum Vöcklabruck Vöcklabruck, Austria
Active, not recruiting
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study
NCT04071223
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +22 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Rush MD Anderson Cancer Center Chicago, Illinois, United States
Active, not recruiting
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
NCT04514484
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
Active, not recruiting
CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer
NCT05122546
- Conditions
- Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, +26 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States